Israel's Sol-Gel signs Canadian licensing deal for Twyneo, Epsolay (NASDAQ:SLGL)

Israel's Sol-Gel (SLGL) has signed an exclusive licensing deal with Searchlight Pharma for the Canadian commercialization rights to its dermatology products Twyneo and Eposolay.

Related Keywords

Canada ,Israel ,Canadian , ,Antibiotics In Laboratory ,Screen Showing Virus Analysis Software User Interface ,Research Scientist ,Female Research Scientist ,Bioengineer Working ,Personal Computer ,Screen Showing Virus Analysis Software User ,Scientists Developing Vaccine ,Searchlight Pharma ,